Velie, Brandon D.
Solé, Marina
Fegraeus, Kim Jäderkvist
Rosengren, Maria K.
Røed, Knut H.
Ihler, Carl-Fredrik
Strand, Eric
Lindgren, Gabriella
Funding for this research was provided by:
Swedish-Norwegian Foundation for Equine Research (H-15-47-075)
Article History
Received: 27 November 2018
Accepted: 14 May 2019
First Online: 27 May 2019
Ethics approval and consent to participate
: All experimental procedures and sample collection methods were approved by the Ethics Committee for Animal Experiments in Uppsala, Sweden [Number: C 121/14]. Samples used in this study were already available at either the Animal Genetics Laboratory at SLU in Uppsala, Sweden or the Department of Basic Sciences and Aquatic Medicine at the Norwegian University of Life Sciences in Oslo, Norway, since they had been previously used for parentage testing. Permission to use the samples was granted from the Swedish Trotting Association and the Norwegian Trotting Association (the owners of the samples per the rules/guidelines of the industry).
: Not applicable.
: The authors have the following interests: GL is a co-inventor on a granted patent concerning commercial testing of the DMRT3 mutation: A method to predict the pattern of locomotion in horses. PCT EP 12,747,875.8. European patent registration date: 2011-05-05, US patent registration date: 2011-08-03. There are no further patents, products in development, or marketed products to declare.